Opheim E, Dalgard O, Ulstein K, Sørli H, Backe Ø, Foshaug T, Couëssurel Wüsthoff LE, Midgard H(2023) Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs Int J Drug Policy, 123, 104279(in press) DOI 10.1016/j.drugpo.2023.104279, PubMed 38061225
Mikalsen IM, Breder S, Medhus AW, Folseraas T, Aabakken L, Ånonsen KV(2023) ERCP for the initial management of malignant biliary obstruction - real world data on 596 procedures Scand J Gastroenterol, 1-9(in press) DOI 10.1080/00365521.2023.2282375, PubMed 37994406
Midgard H, Malme KB, Pihl CM, Berg-Pedersen RM, Tanum L, Klundby I, Haug A, Tveter I, Bjørnestad R, Olsen IC, Finbråten AK, Dalgard O(2023) Opportunistic treatment of hepatitis C infection among hospitalized people who inject drugs (OPPORTUNI-C): A stepped wedge cluster randomized trial Clin Infect Dis(in press) DOI 10.1093/cid/ciad711, PubMed 37992203